A Role for Immune-Oncology + Locoregional Therapy in HCC

The FDA granted fast track designation to opamtistomig for first-line treatment of advanced or metastatic biliary tract cancer.

A planned interim analysis of the radiopharmaceutical RYZ101 showed improved PFS by blinded independent central review vs standard of care.

The top 5 OncLive TV videos of the week.

Check out this September recap of OncLive’s coverage of the top news and expert insights in gastrointestinal cancers.

Experts spotlight the gastrointestinal cancer presentations they’re most excited to see at the 2026 ESMO Congress.

Here is your cheat sheet to all therapeutic options that were cleared by the FDA in September 2026 spanning tumor types.

The top 5 OncLive TV videos of the week cover insights in MDS, multiple myeloma, pancreatic cancer, colorectal cancer, and uveal melanoma.

The combination nearly doubled the confirmed response rate in the randomized phase 2 portion of HexAgon-HN, with the greatest benefit in HPV-positive disease.